ArriVent BioPharma, Inc. (AVBP) Earnings
NASDAQ·Healthcare·Biotechnology
$31.01
+5.26%
Mkt Cap $1.43B
EPS — Estimate vs Actual
Mkt Cap
$1.43B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.53
NASDAQ·Healthcare·Biotechnology
$31.01
+5.26%
Mkt Cap $1.43B
Mkt Cap
$1.43B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$3.53